GL1X · GenesisL1 explorer

MolNFT v1 · #40768 · protein

Crystal structure of a human factor xa inhibitor complex

2J34 · Activated factor xa heavy chain: “Crystal structure of a human factor xa inhibitor complex”. X-ray diffraction, 2 ligands (GS6, CA), 3 pockets (best druggability 0.48). MolNFT v1 #40768 on GenesisL1: 3D structure, binding sites and…

PDB
2J34
Type
protein
Length
286 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Activated factor xa heavy chain; Factor X light chain
EC
3.4.21.6
UniProt
P00742
Ligands
GS6, CA
Pockets
3 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 13% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AActivated factor xa heavy chain (EC 3.4.21.6)protein23413% helix, 36% strandP00742
BFactor X light chain (EC 3.4.21.6)protein5213% helix, 31% strandP00742

Ligands and binding sites

  • GS6 · 6-chloro-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12020.480.7526empty
21170.480.8025GS6
3660.360.7822empty

Interfaces

1 interface between chains.

  • A–B · 881 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 2J34 · Crystal structure of a human factor xa inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P00742 · AlphaFold monomer V2.0 prediction for coagulation factor X (P00742) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.